Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation

Immunology and Cell Biology

Volumn 90, Issue 4, 2012, Pages 441-448

  Kim, So Yong ^a   Moon, Keun Ai ^b   Jo, Hee Yeon ^a   Jeong, Sookyung ^a   Seon, Seung Han ^a   Jung, Eunyu ^a   Cho, You Sook ^b   Chun, Eunyoung ^a,c   Lee, Ki Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

apocynin; asthma; inflammation; NADPH oxidase; NF B; oxidative stress

Indexed keywords

ANTIINFLAMMATORY AGENT; APOCYNIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG FLUID; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA;

ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PNEUMONIA; TRANSCRIPTIONAL ACTIVATION;

EID: 84859953055     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.60     Document Type: Article

References (41)

1. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001; 344: 350-362. (Pubitemid 32107645)
2. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305: 1776-1779. (Pubitemid 39249645)
3. Kim TB, Kim SY, Moon KA, Park CS, Jang MK, Yun ES et al. Five-aminoimidazole-4-carboxamide-1-beta-4 ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma. Clin Exp Allergy 2007; 37: 1709-1719. (Pubitemid 47609844)
4. Renz H. Soluble interleukin-4 receptor (sIL-4R) in allergic diseases. Inflamm Res 1999; 48: 425-431. (Pubitemid 29410676)
5. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54: 825-857. (Pubitemid 29401546)
6. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16: 534-554.
7. Dworski R. Oxidant stress in asthma. Thorax 2000; 55: S51-S53.
8. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 2003; 36: 95-109. (Pubitemid 36836261)
9. Barnes PJ. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990; 9: 235-243.
10. Henricks PA, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001; 14: 409-420.
11. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003; 35: 213-225. (Pubitemid 37288922)
12. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192: 455-462. (Pubitemid 30629171)
13. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003; 111: v291-v297.
14. Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 2006; 18: 718-726. (Pubitemid 44635184)
15. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355: 2226-2235. (Pubitemid 44791164)
16. Umetsu DT, Dekruyff RH. Immune dysregulation in asthma. Curr Opin Immunol 2006; 18: 727-732. (Pubitemid 44635177)
17. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signalling. Oncogene 1999; 18: 6104-6111.
18. Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 2002; 14: 879-897. (Pubitemid 35247561)
19. Miller AA, Drummond GR, Sobey CG. Reactive oxygen species in the cerebral circulation: are they all bad? Antioxid Redox Signal 2006; 8: 1113-1120. (Pubitemid 44182411)
20. Babior BM. NADPH oxidase: an update. Blood 1999; 93: 1464-1476. (Pubitemid 29102471)
21. Griendling KK, Harrison DG. Dual role of reactive oxygen species in vascular growth. Circ Res 1999; 85: 562-563. (Pubitemid 29431958)
22. Van Heerebeek L, Meischl C, Stooker W, Meijer CJ, Niessen HW, Roos D. NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 2002; 55: 561-568.
23. Ogawa Y, Kobayashi T, Nishioka A, Kariya S, Hamasato S, Seguchi H et al. Radiation-induced oxidative DNA damage, 8-oxoguanine, in human peripheral T cells. Int J Mol Med 2003; 11: 27-32.
24. Genova ML, Pich MM, Bernacchia A, Bianchi C, Biondi A, Bovina C et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann NY Acad Sci 2004; 1011: 86-100. (Pubitemid 38608395)
25. Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999; 48: 41-47. (Pubitemid 29512983)
26. Lee YJ, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999; 274: 19792-19798.
27. Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal 2003; 5: 781-788. (Pubitemid 37462061)
28. Tonks NK. Redox redux: revisiting PTPs and the control of cell signalling. Cell 2005; 121: 667-670. (Pubitemid 40797589)
29. Hougee S, Hartog A, Sanders A, Graus YM, Hoijer MA, Garssen J et al. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur J Pharmacol 2006; 531: 264-269. (Pubitemid 43202245)
30. Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F et al. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 2002; 9: 191-203. (Pubitemid 35021589)
31. Stolk J, Hiltermann TJN, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994; 11: 95-102.
32. Muijsers RB, van Den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS et al. Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol 2000; 130: 932-936. (Pubitemid 30389075)
33. Sadeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AK, van der Linde HJ, van Ark I et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 1996; 153: 1697-1701. (Pubitemid 26142839)
34. Chen CC, Chow MP, Huang WC, Lin YC, Chang YJ. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol 2004; 66: 683-693.
35. Wang T, Zhang X, Li JJ. The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2002; 2: 1509-1520. (Pubitemid 35223232)
36. Peters EA, Hiltermann JT, Stolk J. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med 2001; 31: 1442-1447. (Pubitemid 33145314)
37. MacFarlane PM, Satriotomo I, Windelborn JA, Mitchell GS. NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation. J Physiol 2009; 587: 1931-1942.
38. Coyoy A, Valencia A, Guemez-Gamboa A, Morán J. Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons. Free Radic Biol Med 2008; 45: 1056-1064.
39. Kim SY, Kim TB, Moon KA, Kim TJ, Shin D, Cho YS et al. Regulation of proinflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo. Exp Mol Med 2008; 40: 461-476.
40. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schröder K et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008; 51: 211-217. (Pubitemid 351159930)
41. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P et al. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol 2011; 81: 636-648.